You are here

• Home
• Drug Products
• All Drug Products

• A Study to Assess the Absolute Bioavailability of a Single Oral Dose of Fostamatinib with Respect to an Intravenous Micro Tracer Dose of [14C] R406 in Healthy Male Volunteers

Disease

bioavailability

Drug Name

Fostamatinib Disodium

Generic Name

Fostamatinib

Sponsor

AstraZeneca

Drug Status

In Development

Phase

I

Start Date

May 29, 2012

Study Name

QBR112696

Study Id

D4300C00027

ClinicalTrials.gov ID

NCT01598571

Recruiting Status

Closed

Protocol Status

Not Available

Report Status

Not Available

Page tools

• Print
• Bookmark this page